Literature DB >> 16717077

Molecular analysis of pericardial fluid: a 7-year experience.

Pierre-Yves Levy1, Pierre-Edouard Fournier, Remy Charrel, Dominique Metras, Gilbert Habib, Didier Raoult.   

Abstract

AIMS: Aetiological investigations of pericardial effusion are often negative. We evaluate the interest of systematic analysis of fluid in order to diminish the number of pericarditis classified as idiopathic. METHODS AND
RESULTS: We performed a systematic analysis of pericardial fluid and biopsy specimens, using cultures and molecular analyses for the identification of bacteriological, fungal, and viral agents, as well as histopathological examination of 106 pericardial fluid samples. The aetiological diagnosis was determined clinically and by non-invasive procedures in 40 and nine patients, respectively. In the remaining 57 patients, 14 neoplasias and 17 infections were diagnosed. Molecular procedures identified seven viral (Enterovirus, Herpes simplex virus, and Epstein-Barr virus in four, two, and one of the cases, respectively), one fungal (Cryptococcus neoformans), and nine bacterial infections. Four of these bacteria were not diagnosed by culture because of prior antibiotics treatment (Mycobacterium tuberculosis in two cases, Streptococcus pneumoniae in one case, and Actinomyces neuii in one case). The aetiology remained undetermined in 26 patients.
CONCLUSION: The systematic use of molecular techniques permitted a significant increase in aetiological diagnoses of punctured pericardial effusions when compared with cultures (39.5 vs. 13.9%, respectively; P<0.01). It is particularly beneficial for patients with a previous antibiotic regimen or suspicion of tuberculosis.

Entities:  

Mesh:

Year:  2006        PMID: 16717077     DOI: 10.1093/eurheartj/ehl025

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Authors:  Massimo Imazio; Yehuda Adler
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  Real-time PCR strategy and detection of bacterial agents of lymphadenitis.

Authors:  E Angelakis; V Roux; D Raoult; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-14       Impact factor: 3.267

3.  Soft tissue infections caused by Actinomyces neuii, a rare pathogen.

Authors:  José Luis Gómez-Garcés; Almudena Burillo; Yolanda Gil; Juan A Sáez-Nieto
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

Review 4.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 5.  Actinomyces neuii: review of an unusual infectious agent.

Authors:  Alexander von Graevenitz
Journal:  Infection       Date:  2011-02-22       Impact factor: 3.553

6.  Diagnosis and management of pericardial effusion.

Authors:  Jaume Sagristà-Sauleda; Axel Sarrias Mercé; Jordi Soler-Soler
Journal:  World J Cardiol       Date:  2011-05-26

7.  Ventriculoperitoneal shunt infection caused by Actinomyces neuii subsp. neuii.

Authors:  Richard R Watkins; Kathy Anthony; Suzanne Schroder; Gerri S Hall
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

8.  A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report.

Authors:  Detlev Schultze; Brigitt Müller; Thomas Bruderer; Günter Dollenmaier; Julia M Riehm; Katia Boggian
Journal:  BMC Infect Dis       Date:  2012-10-04       Impact factor: 3.090

Review 9.  Infections Caused by Actinomyces neuii: A Case Series and Review of an Unusual Bacterium.

Authors:  Nathan Zelyas; Susan Gee; Barb Nilsson; Tracy Bennett; Robert Rennie
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-02-29       Impact factor: 2.471

10.  [Microbiological diagnosis: Etiologic driven and syndrome driven].

Authors:  F Gouriet; D Raoult
Journal:  Antibiotiques (Paris)       Date:  2008-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.